منابع مشابه
Nocturnal asthma: slow-release terbutaline versus slow-release theophylline therapy.
In a double-blind cross-over study, the effects of slow release (S-R) terbutaline tablets (b.i.d. 0.25 mg/kg per day) and S-R theophylline (5.31 mg/kg morning and 10.62 mg/kg evening) were compared in eleven patients with nocturnal asthma. On day seven of each treatment period, drug serum concentrations and peak expiratory flow (PEF) were measured every 2h over a 24-h period. During daytime, te...
متن کاملSlow release potassium chloride treatment.
-brain levels of HCP varied between 0-442 and 1-204 nmol[g (0-18 and 0 49 ig/g).4 So myelinopathy in case 2 was probably attributable to HCP, despite the absence of clinical signs of toxicity. The trace level in case 1 suggests that myelinopathy was unrelated to HCP, for other causes of infantile spongioform myelinopathy are known, though none has been identified in small premature infants. Nev...
متن کاملCharacterization and Utilization of Zeolite for NPK Slow Release Fertilizer (RESEARCH NOTE)
Based on various characteristics of zeolite, its utilization in the manufacture of fertilizers with slow-release properties is possible. The objectives of this study are to characterize and utilized nitrogen, phosphorus and potassium (NPK) slow release fertilizer by using natural zeolite in Indonesia. In this research, zeolite was utilized as a mixture of Slow Release Fertilizer (SRF). Effect o...
متن کاملSlow release formulations of alachlor 1 Performance of slow-release formulations of alachlor
3 Alachlor [2-chloro-N-(2,6-diethylphenyl)-N-(methoxymethyl)acetamide] is a 4 widely used herbicide that has been identified as a groundwater contaminant. Several 5 slow-release formulations (SRFs) of this herbicide have been examined for their 6 capacity to reduce its leaching and enhance weed control. A field experiment was 7 performed to determine alachlor leaching and bioefficacy in: (i) a ...
متن کاملDevelopment of Slow Release Berberine- Containing Nanoliposome for Delivery to Bone Cancer Cells Saos2
Background: Creating a new berberine liposome with high encapsulation efficiency and slow release formulation in the treatment of cancer is a new issue. Therefore, the aim of current study was to develop slow release berberine-containing nanoliposome for delivery to bone cancer cells Saos2. Materials and Methods: In this experimental study, after synthesis nanoliposomal formulation, physical p...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1976
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.2.6045.1197